Titre
Endobronchial ultrasound in hilar and conventional TBNA-negative/inconclusive mediastinal lymphadenopathy
Type
article
Institution
Externe
Périodique
Auteur(s)
Chhajed, P. N.
Auteure/Auteur
Odermatt, R.
Auteure/Auteur
von Garnier, C.
Auteure/Auteur
Chaudhari, P.
Auteure/Auteur
Leuppi, J. D.
Auteure/Auteur
Stolz, D.
Auteure/Auteur
Tamm, M.
Auteure/Auteur
Liens vers les personnes
ISSN
1998-4138
Statut éditorial
Publié
Date de publication
2011
Volume
7
Numéro
2
Première page
148
Dernière page/numéro d’article
51
Langue
anglais
Notes
Chhajed, Prashant N
Odermatt, Rahel
von Garnier, Christophe
Chaudhari, Parag
Leuppi, Joerg D
Stolz, Daiana
Tamm, Michael
eng
India
J Cancer Res Ther. 2011 Apr-Jun;7(2):148-51. doi: 10.4103/0973-1482.82930.
Odermatt, Rahel
von Garnier, Christophe
Chaudhari, Parag
Leuppi, Joerg D
Stolz, Daiana
Tamm, Michael
eng
India
J Cancer Res Ther. 2011 Apr-Jun;7(2):148-51. doi: 10.4103/0973-1482.82930.
Résumé
OBJECTIVE: Assess the diagnostic yield of real-time bronchoscopic ultrasound transbronchial needle aspiration (EBUS TBNA) in conventional TBNA-negative mediastinal lymphadenopathy and hilar lymphadenopathy. MATERIALS AND METHODS: Sixty-two patients having either conventional TBNA-negative mediastinal lymphadenopathy or hilar lymphadenopathy underwent real-time EBUS TBNA. RESULTS: EBUS TBNA was performed on 72 lymph nodes (mediastinal = 48; and hilar = 24). 31 of the 72 (43%) lymph node samples were positive for malignancy (29) or benign diagnosis (2), and 17 of the 72 (24%) lymph nodes were true negative at EBUS TBNA confirmed at surgery. Out of 48 mediastinal lymph nodes EBUS TBNA was diagnostic for malignancy in 19 (40%) and negative in 14 of which 12 (86%) were surgically confirmed true negative and 2 (14%) false negative. In 10 of the 24 (42%) hilar lymph nodes, EBUS TBNA was diagnostic for malignancy while 5 were true negative and 1 false negative. All false-negative lymph nodes were PET positive. Adequacy of EBUS TBNA based on positive aspiration and surgically confirmed true negative was 67% and in patients suspected for malignancy was 77%. CONCLUSIONS: EBUS TBNA has a good diagnostic yield in hilar lymphadenopathy and in conventional TBNA-negative mediastinal lymphadenopathy.
PID Serval
serval:BIB_73AF78BC49AD
PMID
Date de création
2021-04-15T08:58:50.168Z
Date de création dans IRIS
2025-05-20T22:27:11Z